In systemic inflammatory disorders, the degranulation of platelets as demonstrated by decreases in mean platelet component has provided evidence of in vivo activation
In systemic inflammatory disorders, the degranulationof platelets as demonstrated by decreases in meanplatelet component has provided evidence of in vivo activation